sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sarscov
strain
clinic
similar
mani
acut
respiratori
infect
symptom
includ
high
fever
chill
rigor
dyspnea
nonproduct
cough
myalgia
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
sarscov
strain
clinic
similar
mani
acut
respiratori
infect
symptom
includ
high
fever
chill
rigor
dyspnea
nonproduct
cough
myalgia
lymphopenia
chest
infiltr
begin
incub
period
day
sar
initi
appear
southern
china
end
first
recogn
new
diseas
entiti
world
health
organ
infectiousdiseas
expert
carlo
urbani
begin
sar
spread
countri
epidem
last
week
affect
peopl
die
nosocomi
transmiss
sarscov
strike
featur
epidem
anoth
sar
epidem
occur
surveil
effort
contain
secondari
transmiss
sarscov
would
ideal
combin
better
prophylact
therapeut
measur
despit
substanti
number
case
intens
studi
conduct
mechan
protect
immun
respons
sarscov
remain
unknown
understand
magnitud
specif
qualiti
antisarscov
immun
respons
import
pursu
particularli
infect
patient
develop
sever
lifethreaten
diseas
conceiv
patient
mild
diseas
variou
adapt
innat
immun
respons
cooper
control
eventu
erad
sarscov
infect
vivo
cellmedi
antivir
mechan
cov
involv
cell
express
ab
gd
cell
receptor
tcr
thu
analyz
month
onset
diseas
ab
gd
cell
profil
health
care
worker
hcw
sar
convalesc
schcw
contrast
measur
chang
popul
peripheralblood
ab
cell
effector
memori
cell
popul
select
expand
peripher
blood
schcw
addit
cell
abl
inhibit
sarscov
replic
vero
cell
vitro
kill
sarscovinfect
target
cell
suggest
potenti
role
cell
sar
immunosurveil
patient
materi
method
chang
effector
memori
peripheralblood
cell
subset
analyz
schcw
mean
sd
age
year
men
women
peripheralblood
mononuclear
cell
pbmc
collect
month
onset
diseas
fever
last
mean
sd
day
mean
sd
antisarscovspecif
igg
titer
measur
elisa
eleven
put
healthi
volunt
mean
sd
age
year
men
women
infect
sarscov
serv
control
subject
schcw
control
subject
recruit
princ
wale
hospit
hong
kong
present
studi
approv
institut
ethic
committe
vb
vd
cell
repertoir
schcw
control
subject
studi
flow
cytometri
tcr
chainspecif
monoclon
antibodi
mab
beckman
coulter
isotypematch
control
mab
bd
bioscienc
use
measur
background
stain
pbmc
isol
leucosep
centrifug
arnica
accord
manufactur
instruct
incub
individu
mab
min
wash
pb
contain
bovin
serum
albumin
sodium
azid
fix
paraformaldehyd
immedi
analyz
use
facscalibur
flow
cytomet
bd
bioscienc
express
molecul
vb
vd
cell
analyz
use
mab
bd
bioscienc
blood
sampl
obtain
convalesc
healthi
person
normal
lymphocyt
count
percentag
chang
also
like
reflect
quantit
differ
cell
subset
distribut
gd
cell
control
subject
purifi
use
magnet
microbead
miltenyi
biotech
stimul
isopentenyl
pyrophosph
ipp
mmoll
sigma
plu
interleukin
il
uml
boehring
mannheim
cocultur
vero
cell
evalu
noncytolyt
antivir
activ
cellreleas
solubl
factor
gd
cell
plate
vero
cellsml
cultur
medium
vero
cell
cultur
maintain
flatbottom
plate
separ
stimul
gd
cell
semiperm
polycarbon
membran
pore
size
transwel
bd
labwar
h
vero
cell
cultur
infect
sarscov
moi
supernat
collect
day
afterward
tcid
per
millilit
determin
describ
elsewher
rna
extract
use
nuclisen
isol
reagent
nasba
diagnost
organon
teknica
number
sarscov
rna
copi
assess
realtim
polymeras
chain
reaction
artu
moreov
cell
line
express
cell
obtain
stimul
pbmc
control
subject
ipp
mmol
l
uml
day
cell
line
stimul
ipp
anoth
h
supernat
contain
factor
releas
activ
gd
cell
term
gd
factor
gdf
cultur
dilut
ad
vero
cell
cultur
cellsml
addi
tional
h
cultur
infect
sarscov
moi
twentyfour
hour
infect
vero
cell
cultur
supernat
collect
tcid
per
millilit
determin
cytokin
neutral
assay
perform
use
polyclon
rabbit
antiinterferon
ifn
g
origin
titer
neutral
unitsml
concentr
antibodi
ifng
uml
higher
requir
neutral
ifng
present
supernat
cultur
gd
cell
stimul
mmoll
ipp
function
activ
cell
requir
speciesspecif
interact
target
cell
vero
monkey
kidney
cell
could
use
human
cell
stimul
experi
therefor
use
cell
human
monocyt
cell
line
infect
sarscov
vitro
specif
cell
line
cocultur
uninfectedand
sarscovinfect
cell
moi
ratio
h
cultur
supernat
cocultur
analyz
presenc
ifng
elisa
tema
ricerca
percentag
dead
cell
determin
propidium
iodid
label
hypodiploid
nuclei
h
cocultur
result
rel
frequenc
differ
vb
vd
cell
subset
peripher
blood
schcw
control
subject
shown
figur
although
vb
cell
profil
figur
effector
memori
ab
cell
profil
figur
significantli
alter
schcw
compar
control
subject
substanti
expans
cell
popul
observ
schcw
figur
inset
represent
naiv
fulli
differenti
effector
cell
significantli
differ
mannwhitney
u
test
p
group
contrast
central
effector
memori
subset
significantli
mannwhitney
u
test
expand
p
schcw
compar
control
subject
figur
inset
interestingli
higher
number
circul
cell
associ
higher
antisarscovspecif
igg
titer
titer
mannwhitney
u
test
therep
p
fore
conceiv
sarscov
infect
induc
cell
respons
may
involv
antisarscov
immunosurveil
vivo
subsequ
experi
perform
assess
noncytolyt
antivir
activ
solubl
factor
releas
cell
use
vitro
system
vero
cell
infect
sarscov
figur
freshli
purifi
gd
cell
gd
cell
line
use
initi
gd
cell
control
subject
purifi
magnet
microbead
select
stimul
ipp
gd
cell
cocultur
sarscovinfect
vero
cell
separ
gd
cell
semiperm
membran
addit
cell
line
obtain
stimul
pbmc
control
subject
ipp
result
gd
cell
line
restimul
ipp
supernat
cultur
contain
solubl
molecul
releas
ippactiv
cell
line
test
antisarscov
activ
experi
demonstr
presenc
gdf
sarscovinfect
vero
cell
cultur
substanti
reduc
quantiti
sarscov
infecti
unit
measur
tcid
produc
system
compar
control
cultur
figur
also
total
viral
load
measur
number
sarscov
rna
copi
consider
decreas
presenc
gdf
interestingli
antisarscov
activ
gdf
complet
abolish
addit
antibodi
ifng
figur
result
strongli
suggest
ifng
least
partial
respons
observ
antivir
action
gdf
addit
experi
demonstr
gdf
complement
ifna
block
sarscov
replic
data
shown
confirm
synergist
sarscovinhibitori
activ
human
type
type
ii
ifn
final
cocultur
use
assess
cytotox
function
cytokin
product
result
demonstr
product
ifng
augment
cell
stimul
sarscov
vitro
pg
ml
uninfect
cocultur
vs
pgml
sarscovinfect
cocultur
figur
addit
analysi
hypodiploid
nuclei
demonstr
substanti
increas
cytotox
cell
sarscovinfect
target
cell
compar
uninfect
target
cell
thu
appear
sarscov
infect
cell
promot
cytotox
effector
function
cell
discuss
role
play
tcellmedi
immun
sarscov
infect
well
understood
one
trait
sar
rapid
develop
lymphopenia
cell
sever
reduc
cell
acut
infect
recov
patient
peripher
ab
cell
subset
rapidli
restor
suggest
tissu
sequestr
may
contribut
decreas
lymphocyt
count
acut
sar
addit
ab
cell
respons
sarscov
spike
protein
epitop
observ
patient
recov
sar
inde
certain
hla
class
molecul
may
direct
cell
respons
confer
either
protect
increas
suscept
vbspecif
chang
measur
schcw
month
onset
diseas
indic
oligoclon
ab
cell
respons
might
occur
persist
peripher
blood
form
detect
mab
analysi
sarscov
protein
contain
superantigen
sag
domain
may
play
crucial
role
target
host
cell
interf
immun
system
sag
protein
produc
certain
bacteria
mycoplasma
virus
stimul
larg
number
cell
express
specif
variabl
region
tcr
b
chain
present
studi
analyz
tcr
vb
repertoir
schcw
differ
observ
frequenc
differ
vb
chain
effector
memori
vb
cell
subset
peripher
blood
schcw
control
subject
typic
sag
respons
expect
induc
signific
perturb
vb
cell
repertoir
result
specif
delet
expans
select
vb
cell
subset
therefor
light
data
involv
vbspecif
sag
immunopathogenesi
sar
appear
unlik
howev
effector
memori
cell
popul
select
expand
peripher
blood
schcw
cell
display
broad
antivir
activ
differ
virus
includ
retrovirus
flavivirus
paramyxovirus
orthomyxovirus
picornavirus
cov
rhabdovirus
arenavirus
herpesvirus
hepadnavirus
orthopoxvirus
antivir
action
gd
cell
may
play
import
defens
role
especi
given
rel
larg
number
eg
adult
human
pbmc
cell
abil
respond
quickli
typic
antigen
process
requir
saglik
activ
cell
molecul
recogn
gd
cell
viral
infect
probabl
cellular
rather
viral
origin
may
metabolit
alter
cellular
pathway
moreov
virusexpos
gd
cell
rapidli
activ
type
ifn
ifna
ifnb
phenomenon
like
contribut
effect
antivir
respons
thu
potenti
involv
possibl
gdspecif
sag
sarsassoci
immun
respons
exclud
antivir
role
play
gd
cell
intens
studi
mice
found
correl
product
ifng
distinct
gd
cell
subset
rodent
model
cov
infect
infect
mous
hepat
viru
mhv
cell
express
gd
tcr
appear
major
cell
effector
found
predominantli
area
viru
replic
mhvinfect
mice
gd
cell
may
function
lyse
infect
target
cell
secret
proinflammatori
cytokin
could
import
antimhv
respons
vivo
experi
observ
cell
abl
exert
potent
cytolyt
activ
sarscovinfect
target
cell
remark
similar
receptor
rodent
human
may
support
role
ligand
recognit
kill
covinfect
cell
present
studi
cell
appear
abl
inhibit
sarscov
replic
vitro
ifngdepend
process
recent
dandekar
et
al
shown
gd
cell
mediat
demyelin
mice
infect
mhv
strain
jhm
ifng
critic
player
process
activ
ctype
lectin
nk
cell
receptor
recogn
potent
costimul
cytotox
function
human
cell
data
exclud
possibl
ligand
may
involv
recognit
kill
sarscovinfect
cell
furthermor
result
compat
idea
cell
contribut
antisar
innat
immun
respons
employ
cytotox
noncytolyt
antivir
mechan
activ
human
cell
may
promot
antigen
process
present
provid
costimulatori
signal
dendrit
ab
cell
therefor
may
also
particip
induct
adapt
immun
respons
sarscov
noteworthi
vitro
vivo
activ
cell
stimul
mani
nonpeptid
molecul
includ
nitrogencontain
bisphosphon
frequent
use
treatment
bonedeminer
disord
pyrophosphomonoest
drug
current
test
phase
cancer
trial
rel
low
vivo
toxic
mani
drug
may
facilit
novel
approach
treatment
sarscov
infect
includ
one
could
base
type
ii
ifn
releas
activ
cell
combin
type
ifn
chemotherapi
